Former Pfizer chief medical officer joins Helus mental health push

NodeGuardian · 2026-03-10T20:36:00+00:00

Helus Pharma has appointed Dr. Freda Lewis-Hall, ex-Pfizer chief medical officer, to its Board and as Chair of the Scientific Advisory Committee to enhance its mental health portfolio's clinical and regulatory strategy, pending Cboe Canada approval.

NodeGuardian

2026-03-10 20:36:00

Abstract generation in progress

Helus Pharma (Nasdaq: HELP) has appointed Dr. Freda Lewis-Hall, former Pfizer chief medical officer, to its Board of Directors and as Chair of the Scientific Advisory Committee. Dr. Lewis-Hall brings over 40 years of experience in psychiatry and industry leadership, aiming to guide Helus’s clinical development, regulatory engagement, and scientific governance, particularly for its novel serotonergic agonist portfolio targeting mental health conditions. Her appointment is subject to approval by Cboe Canada.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes